Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/1999
11/25/1999CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/25/1999CA2332803A1 Multi-action particle for structuring biological media
11/25/1999CA2332507A1 Angiostatin receptor
11/25/1999CA2332505A1 Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
11/25/1999CA2332279A1 Carboxamide compounds, compositions, and methods for inhibiting parp activity
11/25/1999CA2332272A1 Novel analogs of 16-hydroxyeicosatetraenoic acid
11/25/1999CA2332239A1 Fused tricyclic compounds which inhibit parp activity
11/25/1999CA2331875A1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same
11/25/1999CA2331318A1 Compositions comprising 2-phenyl-indole compounds and estrogen formulations
11/25/1999CA2329916A1 Potassium channel agonists
11/25/1999CA2329868A1 Compounds, screening methods, and uses involving anti-apoptotic genes and gene products
11/25/1999CA2329530A1 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
11/25/1999CA2328527A1 Secreted proteins
11/24/1999EP0958828A1 Artichoke containing preparation especially for use as medicaments or nutritional supplement
11/24/1999EP0958363A1 Human regulator of g-protein signaling - (hrgs)
11/24/1999EP0958294A1 2-(1,2,4-triazole-1-yl)-1,3,4-thiadiazole derivatives having an effect on the c.n.s. and the heart
11/24/1999EP0958290A1 1,4-dihydropyridin derivatives and their use in therapy
11/24/1999EP0958282A1 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines
11/24/1999EP0958280A1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
11/24/1999EP0957917A1 Vitronectin receptor antagonists
11/24/1999EP0957907A1 Il-8 receptor antagonists
11/24/1999EP0957901A1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/24/1999EP0550703B1 Plant-based medicament for enhancing and controlling the tone of smooth-muscle organs
11/24/1999EP0495091B1 Aica riboside analogs
11/24/1999CN1236390A Angiogenic factor and use thereof of treating cardiovascular disease
11/24/1999CN1236362A Azinyloxy- and phenoxy-diaryl-carboxylic derivatives, their preparation and use as mixed ET/ET encothelin receptor
11/24/1999CN1236359A Bi-aromatic compounds bond by a heteroethynytene radical and pharmaceutical and comsmetic compositions containing same
11/24/1999CN1236354A Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cometic compositions containing same
11/24/1999CN1236313A Novel methods
11/24/1999CN1236299A Method of treating post menopausal diseases, including osteoporosis
11/24/1999CN1046724C Pyrazolopyridine compounds, pharmaceutical containing them, and its preparing method and use
11/24/1999CN1046723C Tetracyclic compounds, pharmaceutical containing them and its use
11/24/1999CN1046714C Diaryloxazole derivatives and its preparing method use and pharmaceutical composition
11/24/1999CN1046711C Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
11/24/1999CN1046710C aminopyridines, process for preparing the same and use and medicaments containing the same
11/23/1999US5990280 Factor which is heat resistant but sensitive to acidic and alkaline conditions, does not bind heparin, induced by wild type p53 expression, is not thrombospondin, molecular weight of about 100 kilodaltons; diagnosis, anticarcinogenic agents
11/23/1999US5990170 Possesses a profile of activity which is similar to, though less potent than .delta.9-thc (tetrahydrocannabinol) with a mimicking of the psychoactive effects; analgesics; side effect reduction; cardiovascular disorders
11/23/1999US5990158 Carboxylic acid derivatives, method of manufacturing the same and therapeutic agents containing these compounds
11/23/1999US5990150 Heterocyclic derivatives, method of production thereof and pharmaceutical use thereof
11/23/1999US5990145 Antiinflammatory,-carcinogenic,-tumor,-metastasis agents; cardiovascular disorders, e.g., arteriosclerosis, restenosis; retinopaathies and nephropathies; osteoporosis
11/23/1999US5990142 Antiinflammatory agents and antiallergens having good oral adsorption and bioavailability; cardiotonic and antiischemic agents
11/23/1999US5990123 For treating migraine and cephalic pain, and conditions related to vasodilation; pharmacuetical compositions and methods of synthesis via reductive n-alkylation
11/23/1999US5990111 Aldose reductase inhibition in preventing or reversing diabetic cardiomyopathy
11/23/1999US5990109 Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
11/23/1999US5990102 Substituted azetidin-2-ones for treatment of atherosclerosis
11/23/1999US5990092 GATA-6 transcription factor: compositions and methods
11/23/1999US5990081 Purified with an immobilized compound with 2 or 3 nitrogen atoms strongly attaches the endotoxins, and thereby the apoliproteins (apo a or apo e) to the matrix; elution with a surfactant solution releases apo; cardiovascular disorders
11/23/1999US5989866 FGF homologs
11/23/1999US5989864 DNA encoding spo-rel polypeptides
11/23/1999US5989858 Dead-type ATP-dependent RNA helicase (DbpB) from Staphylococcus aureus
11/23/1999US5989803 Method for treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase
11/23/1999US5989558 Extracting leaves with aqueous ethanol
11/23/1999US5989557 Process for extracting polyphenol fractions of tea and compositions produced therewith
11/18/1999WO1999058642A2 Secreted proteins and polynucleotides encoding them
11/18/1999WO1999058572A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis
11/18/1999WO1999058531A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058528A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999WO1999058527A2 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
11/18/1999WO1999058525A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999WO1999058524A1 Benzocarbazole and indenoindole derived estrogenic agents
11/18/1999WO1999058523A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/18/1999WO1999058514A1 (2-acylaminothiazole-4-yl)acetic acid derivatives
11/18/1999WO1999058510A1 Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
11/18/1999WO1999058505A2 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
11/18/1999WO1999058502A1 Heterocyclic inhibitors of p38
11/18/1999WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999WO1999058132A1 Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis
11/18/1999WO1999058123A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis
11/18/1999WO1999058122A1 Novel fatty analogues for the treatment of diabetes
11/18/1999WO1999058121A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver
11/18/1999WO1999058120A1 USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
11/18/1999WO1999058119A1 Administration of resveratrol to prevent or treat restenosis following coronary intervention
11/18/1999WO1999058096A2 Analogs of 2-phthalimidinoglutaric acid and their use as inhibitors of angiogenesis
11/18/1999WO1999050239A3 Novel heteroethynylene compounds and pharmaceutical and cosmetic compositions containing same
11/18/1999WO1999049909A3 Revascularization apparatus having coaxial channeling and injecting means
11/18/1999WO1999046364A9 Vascular endothelial growth factor 2
11/18/1999WO1999046283A9 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
11/18/1999WO1999046281A9 Novel polypeptides and nucleic acids encoding the same
11/18/1999DE19822036A1 Effervescent pharmaceutical composition with improved stability
11/18/1999DE19821483A1 New imidazolidine derivatives useful as leukocyte adhesion and migration inhibitors and/or VLA-4 receptor antagonists for treating E.G. inflammatory and allergic disorders
11/18/1999CA2332275A1 Benzofuran derivatives, pharmaceutical composition containing the same, and a process for the preparation of the active ingredient
11/18/1999CA2331879A1 Oxyiminoalkanoic acid derivatives
11/18/1999CA2331878A1 1,5-diaryl substituted pyrazoles as p38 kinase inhibitors
11/18/1999CA2331631A1 Benzocarbazoles and indenoindoles as estrogenic agents
11/18/1999CA2331295A1 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer
11/18/1999CA2330796A1 Indole derivatives as 5-ht2a ligands and as serotonine reuptake inhibitors
11/18/1999CA2330558A1 (2-acylaminothiazole-4-yl)acetic acid derivatives
11/18/1999CA2330108A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2330095A1 Substituted aryl hydroxamic acids as metalloproteinase inhibitors
11/18/1999CA2328062A1 Secreted proteins and polynucleotides encoding them
11/17/1999EP0957172A2 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle
11/17/1999EP0957103A1 Oxazolidinone derivatives useful as antiarrhythmic and antifibrillatory agents
11/17/1999EP0957099A2 Heterocyclic carboxamides
11/17/1999EP0957087A2 Enzyme inhibitors
11/17/1999EP0956865A1 MEDICINES COMPRISING Rho KINASE INHIBITOR
11/17/1999EP0956854A1 Pharmaceutical composition comprising coenzyme q 10
11/17/1999EP0956358A2 Cd95 regulatory gene sequences and transcription factors
11/17/1999EP0956342A1 Methods for identifying vasoprotective agents
11/17/1999EP0956289A1 Novel prokaryotic polynucleotides, polypeptides and their uses
1 ... 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 ... 1595